Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bambusa | 5 | 2012 | 10 | 1.840 |
Why?
|
| Plant Extracts | 6 | 2012 | 286 | 1.800 |
Why?
|
| Palmitic Acid | 5 | 2016 | 24 | 1.300 |
Why?
|
| Mitochondria | 3 | 2020 | 487 | 1.240 |
Why?
|
| Chemokine CCL2 | 3 | 2012 | 85 | 1.150 |
Why?
|
| Glutathione | 6 | 2014 | 179 | 0.940 |
Why?
|
| Oxidative Stress | 10 | 2015 | 938 | 0.880 |
Why?
|
| Poaceae | 2 | 2012 | 11 | 0.810 |
Why?
|
| Phytotherapy | 3 | 2012 | 81 | 0.800 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 234 | 0.780 |
Why?
|
| Dietary Supplements | 2 | 2012 | 208 | 0.690 |
Why?
|
| Antioxidants | 6 | 2014 | 416 | 0.690 |
Why?
|
| Cholesterol | 1 | 2020 | 205 | 0.650 |
Why?
|
| Methamphetamine | 3 | 2015 | 159 | 0.620 |
Why?
|
| Obesity | 5 | 2018 | 1067 | 0.620 |
Why?
|
| Cognition | 2 | 2020 | 398 | 0.610 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2016 | 643 | 0.540 |
Why?
|
| Drugs, Chinese Herbal | 2 | 2016 | 19 | 0.510 |
Why?
|
| Transcription Factor AP-1 | 2 | 2012 | 35 | 0.490 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 65 | 0.480 |
Why?
|
| Thalamus | 1 | 2014 | 30 | 0.470 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 123 | 0.430 |
Why?
|
| Animals | 21 | 2018 | 15081 | 0.410 |
Why?
|
| Anti-Anxiety Agents | 1 | 2012 | 15 | 0.410 |
Why?
|
| Diabetes Complications | 1 | 2012 | 90 | 0.400 |
Why?
|
| NF-kappa B | 2 | 2012 | 339 | 0.400 |
Why?
|
| Mice | 13 | 2018 | 5913 | 0.400 |
Why?
|
| HIV-1 | 2 | 2014 | 706 | 0.390 |
Why?
|
| Depression | 2 | 2015 | 712 | 0.380 |
Why?
|
| Cell Differentiation | 1 | 2014 | 587 | 0.370 |
Why?
|
| Superoxides | 2 | 2007 | 53 | 0.370 |
Why?
|
| Liver | 2 | 2010 | 479 | 0.370 |
Why?
|
| Interleukin-6 | 1 | 2011 | 153 | 0.360 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 664 | 0.350 |
Why?
|
| Cell Line | 8 | 2018 | 1354 | 0.340 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 29 | 0.330 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2008 | 70 | 0.310 |
Why?
|
| Selenoproteins | 2 | 2007 | 159 | 0.310 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 4 | 0.300 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2007 | 12 | 0.300 |
Why?
|
| Male | 12 | 2020 | 20025 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 168 | 0.280 |
Why?
|
| Pilot Projects | 2 | 2020 | 661 | 0.280 |
Why?
|
| Signal Transduction | 2 | 2012 | 1908 | 0.260 |
Why?
|
| Selenium | 1 | 2007 | 148 | 0.260 |
Why?
|
| Fatty Acids, Nonesterified | 3 | 2016 | 42 | 0.250 |
Why?
|
| Anxiety | 1 | 2012 | 754 | 0.250 |
Why?
|
| Neurons | 4 | 2014 | 1175 | 0.250 |
Why?
|
| DNA-Binding Proteins | 2 | 2007 | 539 | 0.240 |
Why?
|
| HIV Infections | 2 | 2015 | 2303 | 0.230 |
Why?
|
| RNA, Messenger | 4 | 2012 | 1207 | 0.210 |
Why?
|
| Flavonoids | 3 | 2013 | 87 | 0.210 |
Why?
|
| Bile Acids and Salts | 2 | 2018 | 33 | 0.200 |
Why?
|
| Cell Survival | 4 | 2013 | 864 | 0.190 |
Why?
|
| Protein Transport | 2 | 2012 | 302 | 0.190 |
Why?
|
| Plant Leaves | 2 | 2012 | 124 | 0.190 |
Why?
|
| Humans | 15 | 2020 | 37093 | 0.190 |
Why?
|
| Lipase | 1 | 2020 | 18 | 0.180 |
Why?
|
| Stearic Acids | 2 | 2016 | 5 | 0.180 |
Why?
|
| Sulfotransferases | 2 | 2010 | 7 | 0.180 |
Why?
|
| Cell Nucleus | 2 | 2012 | 366 | 0.180 |
Why?
|
| Female | 8 | 2020 | 20969 | 0.180 |
Why?
|
| Rats | 5 | 2016 | 3483 | 0.170 |
Why?
|
| Metabolomics | 2 | 2018 | 81 | 0.170 |
Why?
|
| Liver Failure, Acute | 1 | 2018 | 4 | 0.170 |
Why?
|
| Ammonia | 1 | 2018 | 17 | 0.160 |
Why?
|
| Hepatic Encephalopathy | 1 | 2018 | 11 | 0.160 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 88 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 1609 | 0.160 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 1371 | 0.160 |
Why?
|
| Young Adult | 2 | 2020 | 4268 | 0.160 |
Why?
|
| Oxidation-Reduction | 2 | 2012 | 431 | 0.160 |
Why?
|
| Metabolome | 1 | 2018 | 53 | 0.150 |
Why?
|
| Rats, Transgenic | 2 | 2014 | 27 | 0.150 |
Why?
|
| Hepatitis B, Chronic | 1 | 2017 | 10 | 0.150 |
Why?
|
| Adult | 5 | 2020 | 11712 | 0.150 |
Why?
|
| Feces | 1 | 2017 | 111 | 0.150 |
Why?
|
| Lysophosphatidylcholines | 1 | 2017 | 22 | 0.150 |
Why?
|
| Food | 1 | 2018 | 100 | 0.140 |
Why?
|
| Gastric Bypass | 1 | 2016 | 17 | 0.140 |
Why?
|
| Brain | 2 | 2016 | 1346 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1130 | 0.140 |
Why?
|
| Adrenal Insufficiency | 1 | 2016 | 1 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 52 | 0.140 |
Why?
|
| Protective Agents | 2 | 2016 | 25 | 0.140 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 1015 | 0.140 |
Why?
|
| Carcinoma | 1 | 2017 | 96 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 1039 | 0.130 |
Why?
|
| Buthionine Sulfoximine | 1 | 2005 | 12 | 0.130 |
Why?
|
| Hippocampus | 3 | 2007 | 561 | 0.130 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 190 | 0.120 |
Why?
|
| Longevity | 1 | 2016 | 147 | 0.120 |
Why?
|
| Dementia | 1 | 2015 | 131 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 253 | 0.120 |
Why?
|
| Milk | 1 | 2013 | 50 | 0.110 |
Why?
|
| Sodium Selenite | 1 | 2013 | 4 | 0.110 |
Why?
|
| Milk, Human | 1 | 2013 | 33 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2013 | 111 | 0.110 |
Why?
|
| Drug Therapy | 1 | 2012 | 17 | 0.110 |
Why?
|
| Plant Stems | 1 | 2012 | 10 | 0.100 |
Why?
|
| Receptors, Nicotinic | 1 | 2013 | 106 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 116 | 0.100 |
Why?
|
| Apoptosis | 2 | 2011 | 1398 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2012 | 50 | 0.100 |
Why?
|
| Exploratory Behavior | 1 | 2012 | 75 | 0.100 |
Why?
|
| Middle Aged | 5 | 2018 | 10129 | 0.100 |
Why?
|
| Homeostasis | 1 | 2013 | 188 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2016 | 485 | 0.100 |
Why?
|
| 3T3-L1 Cells | 1 | 2011 | 16 | 0.100 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2011 | 15 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 174 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2011 | 40 | 0.100 |
Why?
|
| Culture Media | 1 | 2011 | 90 | 0.100 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 45 | 0.100 |
Why?
|
| Organ Size | 1 | 2011 | 157 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2011 | 82 | 0.090 |
Why?
|
| Peptide Fragments | 1 | 2013 | 308 | 0.090 |
Why?
|
| Adipocytes | 1 | 2011 | 58 | 0.090 |
Why?
|
| Mice, Obese | 1 | 2010 | 40 | 0.090 |
Why?
|
| Biotransformation | 1 | 2010 | 67 | 0.090 |
Why?
|
| Glucuronosyltransferase | 1 | 2010 | 25 | 0.090 |
Why?
|
| Random Allocation | 1 | 2010 | 139 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 92 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 480 | 0.090 |
Why?
|
| Aging | 1 | 2015 | 664 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2012 | 314 | 0.090 |
Why?
|
| Energy Intake | 1 | 2010 | 170 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 677 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 618 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 247 | 0.080 |
Why?
|
| Diet | 2 | 2016 | 801 | 0.080 |
Why?
|
| Body Weight | 1 | 2010 | 434 | 0.080 |
Why?
|
| Vero Cells | 1 | 2008 | 93 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 578 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 1742 | 0.080 |
Why?
|
| Malonates | 1 | 2007 | 2 | 0.080 |
Why?
|
| Polyenes | 1 | 2007 | 4 | 0.080 |
Why?
|
| Antimycin A | 1 | 2007 | 5 | 0.080 |
Why?
|
| Electron Transport Complex II | 1 | 2007 | 7 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 13 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 4 | 0.080 |
Why?
|
| Rotenone | 1 | 2007 | 19 | 0.080 |
Why?
|
| Apoferritins | 1 | 2007 | 5 | 0.070 |
Why?
|
| Electron Transport Complex I | 1 | 2007 | 21 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2008 | 399 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 117 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 269 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2008 | 859 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 905 | 0.070 |
Why?
|
| Binding Sites | 1 | 2007 | 651 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2007 | 513 | 0.060 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 461 | 0.060 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 1180 | 0.060 |
Why?
|
| Gene Expression | 1 | 2007 | 674 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1618 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 803 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 119 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2016 | 27 | 0.040 |
Why?
|
| 8,11,14-Eicosatrienoic Acid | 1 | 2016 | 4 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2016 | 19 | 0.040 |
Why?
|
| Arachidonic Acid | 1 | 2016 | 35 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 2231 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 88 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 2016 | 43 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2016 | 11 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 138 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2016 | 81 | 0.030 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2016 | 36 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 86 | 0.030 |
Why?
|
| China | 1 | 2016 | 196 | 0.030 |
Why?
|
| Hydrocortisone | 1 | 2016 | 78 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 233 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2016 | 195 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2016 | 142 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 145 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2016 | 107 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 260 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 140 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 421 | 0.030 |
Why?
|
| Infant Formula | 1 | 2013 | 15 | 0.030 |
Why?
|
| Electrochemical Techniques | 1 | 2013 | 22 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 70 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 36 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 33 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 923 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 885 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 245 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 854 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2013 | 435 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2013 | 894 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 2026 | 0.020 |
Why?
|
| Homocysteine | 1 | 2007 | 19 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 12 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 45 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 286 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 306 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 295 | 0.020 |
Why?
|
| Cell Death | 1 | 2007 | 267 | 0.020 |
Why?
|
| Transfection | 1 | 2007 | 523 | 0.020 |
Why?
|
| Neurodegenerative Diseases | 1 | 2007 | 131 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 623 | 0.020 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 6741 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 626 | 0.010 |
Why?
|